title: Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
authors: Ahmed
authors: A
authors: Tawakol
authors: Aloke V
authors: AV
authors: Finn
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001011:Aorta / Q000187:drug effects*; D001018:Aortic Diseases / Q000188:drug therapy*; D001027:Aortography; D050197:Atherosclerosis / Q000175:diagnosis* / Q000188:drug therapy*; D002340:Carotid Artery Diseases / Q000188:drug therapy*; D003287:Contrast Media; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005260:Female; D019788:Fluorodeoxyglucose F18; D018149:Glucose Intolerance / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007249:Inflammation / Q000175:diagnosis* / Q000188:drug therapy*; D018810:Magnetic Resonance Angiography; D008297:Male; D064847:Multimodal Imaging; D000077205:Pioglitazone; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D045162:Thiazolidinediones / Q000494:pharmacology* / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D000893:Anti-Inflammatory Agents; D003287:Contrast Media; D007004:Hypoglycemic Agents; D019275:Radiopharmaceuticals; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D019788:Fluorodeoxyglucose F18; C057619:glimepiride; D000077205:Pioglitazone